Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/9/2025

Insulin Regimen Adjustment for Patients with Hyperglycemia

Current Regimen Assessment

  • The patient's A1C of 9.0% indicates inadequate glycemic control, suggesting the current regimen of sliding scale insulin with 60 units of Lantus is insufficient 1
  • The current basal insulin dose of 60 units may be appropriate or even high, suggesting potential issues with insulin timing, adherence, or inadequate prandial coverage 2, 1
  • Sliding scale insulin alone is not recommended as an effective strategy for glycemic management and should be replaced with a more structured approach 3

Basal Insulin Optimization

  • Assess the adequacy of the current basal insulin dose by evaluating fasting glucose patterns; if consistently elevated, consider a modest increase of 10% (6 units) 1
  • Look for signs of overbasalization (basal dose >0.5 units/kg/day, elevated bedtime-morning glucose differential, or hypoglycemia), which may indicate need for dose reduction rather than increase 1

Adding Structured Prandial Insulin

  • Replace sliding scale with scheduled mealtime insulin, starting with one injection at the largest meal 2, 1
  • Initial prandial dose should be 4 units or 10% of the basal insulin dose (6 units) with the largest meal 1, 4
  • Titrate the prandial insulin dose by 1-2 units or 10-15% twice weekly based on 2-hour post-meal glucose readings 1
  • If A1C remains above target after adding one prandial dose, progressively add prandial insulin to other meals until full basal-bolus coverage is achieved 2, 1

Monitoring and Adjustment Protocol

  • Set fasting plasma glucose target (typically 80-130 mg/dL) and adjust basal insulin by 2 units every 3 days until target is reached without hypoglycemia 1
  • For prandial insulin, target 2-hour postprandial glucose <180 mg/dL 1
  • If hypoglycemia occurs, identify the cause and reduce the corresponding insulin dose by 10-20% 1
  • Reassess the regimen every 3-6 months and adjust as needed 2

Special Considerations

  • Consider adding a GLP-1 receptor agonist if not already on one, which can improve glycemic control while potentially reducing insulin requirements 5, 4
  • Consider prescription of glucagon for emergency hypoglycemia management 2